Sathish K Sankarpandi
Head of Data Science @Orbital Global Group
Signup · Get unlimited contacts
WORK HISTORY
Head of Data Science @Orbital Global Group
Defined and delivered 5-year data and research strategy in line with ethical data policies.Working with C-suite to inform investment decisions.Designing machine learning pipelines and data architecture.Defining new areas to research and transforming the research outputs to commercial value. Providing technical and data science thought leadership.
EDUCATION
Vellore Institute of Technology
B.Tech, Electronics and Instrumentation Engineering
Newcastle University
Doctor of Philosophy (Ph.D.), Elderly falls prediction using wearable sensors data (Machine learning)
ABOUT SATHISH K SANKARPANDI
I\'m a technology executive with 11+ years of experience leading AI innovation in healthcare—from academic research and early-stage startups to cross-industry collaborations with global pharmaceutical leaders. My career has been defined by a consistent ability to take ideas from research or concept through to scalable, regulatory-compliant commercial platforms that deliver measurable impact on patient outcomes, system efficiency, and organizational growth.As CTO at VirtTuri, I lead strategy, architecture, and delivery for AI-powered clinical avatars and decision-support tools. Our platforms have- Reduced hospital readmissions by 75% through intelligent respiratory interventions- Improved mental health and wellness pathways with AI-driven social prescribing and emotional needs diagnostics- Achieved CE marking, GDPR compliance, and adoption in real-world health systemsAs part of the €23M iCare4CVD initiative, I’m spearheading the development of a scalable digital health application that leverages AI precision models, multi-modal data integration (EHRs, wearables, and manual inputs), and AI avatars to personalize cardiovascular care. The platform adheres to strict regulatory standards, including GDPR compliance, HL7 FHIR interoperability, and is being developed under Medical Device Class IIb designation. We’ve completed the Initial Market Device Dossier (IMDD) and are on track to achieve CE and UKCA certifications.The commercial translation of this work is branded as DoctorME, a patient-facing application backed by VC investment, designed to deliver clinically validated, AI-powered cardiovascular interventions at scale.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.